Orthogon Therapeutics
About:
Orthogon Therapeutics is a drug development company.
Website: https://www.orthogontherapeutics.com
Top Investors: Holbrook Angels of Boston, Over-the-Rhine Ventures
Description:
Orthogon Therapeutics is a pre-clinical stage, drug design company that leverages a constellation of innovative technologies to discover and develop small molecules that modulate challenging but sought-after drug targets.
Total Funding Amount:
$12.4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Canton, Massachusetts, United States
Founded Date:
2012-01-01
Contact Email:
info(AT)orthogontherapeutics.com
Founders:
Ali Munawar
Number of Employees:
1-10
Last Funding Date:
2021-11-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai